S&P 500 7,666.45 +0.19%
Nasdaq 26,871.60 +0.04%
S&P/TSX 35,154.76 −0.23%
Apple 330.32 −0.81%
Nvidia 230.86 +1.09%
Microsoft 512.80 −0.02%
Shopify 212.10 +0.56%
Royal Bank 277.86 −0.74%
CAD/USD 0.7035 +0.15%
CLOSED · 01:05 ET
Market ClerkRecap
Fri Oct 2 · markets closed3 signals on Oct 1308 insider buys this week · $10330.5BCIRO short report next: Oct 14The week ahead
HJ
INSIDER · LPCN · Lipocine Inc. · DIRECTOR

Higuchi John W.

Every open-market transaction filed under this name, Sep 28 to Sep 30.

Filings
3
3 buys · 0 sells
Bought
$82K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−5.0%
avg move from buy price, 3 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 30LPCNLipocine Inc.DirectorBuy15,970$2.23$36K−7.2%
Sep 29LPCNLipocine Inc.DirectorBuy9,037$2.15$19K−3.7%
Sep 28LPCNLipocine Inc.DirectorBuy12,561$2.16$27K−4.2%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.